ABOUT US
SCIENCE
FACILITY
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
ABOUT US
SCIENCE
FACILITY
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
INVESTORS
[한국경제] 키메릭항원수용체 T세포(CAR-T) 치료제…내년 하반기 첫 국산 제품 나온다
2024/09/25
키메릭항원수용체 T세포(CAR-T) 치료제…내년 하반기 첫 국산 제품 나온다 | 한국경제 (hankyung.com)
Prev
큐로셀, 2024 대한민국 일자리 으뜸기업 선정
Next
[히트뉴스] “‘차세대 CAR-T 치료제’ 공동개발 파트너 찾으러 바이오 재팬 왔죠”
ABOUT US
SCIENCE
FACILITY
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
ABOUT US
SCIENCE
FACILITY
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
Copyright 2023. Curocell Inc. All Rights Reserved.